Biomonitoring study needs careful interpretation, chemistry industry says
Thanks to advances in analytical chemistry, researchers are able to measure extraordinarily low levels of natural and man-made substances in human fluids and tissues - often as little as one part per billion (a single drop in an Olympic-sized swimming pool). Of course, health researchers know that the simple presence of an environmental chemical in a person's body does not mean that it will cause health effects or disease.
Biomonitoring provides a "snapshot" of the substances present in the body at a single point in time, but it cannot explain where a detected substance came from, when the exposure occurred, or whether there will be any health effects. For those reasons, the Chemistry Industry Association of Canada believes there must be a risk-based process for interpreting biomonitoring results, and for using such data for regulatory purposes or other decision-making.
Most read news
Organizations
Other news from the department politics & laws
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.